Search

everythinglearnresearchcommunity

for

Search:↓

Tacrolimus ointment is effective for various skin conditions but needs more research for long-term effects.

New medications could improve treatment for severe alopecia areata in Australia.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Women with alopecia areata have poor blood flow, possibly due to nerve inflammation.

Advancements in diagnostics, treatments, and technology have improved hair loss detection and restoration, with some types being reversible.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

People with severe hair loss have lower zinc levels in their blood.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

Alopecia areata is hard to treat, but new targeted therapies show promise.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

Targeting CXCL10 may help treat alopecia areata.

FilaggrinHigh melanomas have active FGFR signaling and weak GNA14 and Th1 signatures.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Alopecia areata is influenced by genetics and immune system factors, and better understanding could improve treatments.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Alopecia Areata might be linked to Crohn's disease.

Ustekinumab helped three kids with alopecia areata regrow hair.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Hair growth phase in mice weakens certain immune responses.